Noven Pharmaceuticals, Inc. - NOVN- Profile

Noven Pharmaceuticals, Inc.. The Group's principal activity is to research, develop, manufacture and market advanced transdermal drug delivery products and technologies. The products include first generation transdermal estrogen delivery systems marketed as Vivelle (R), Menorest (R) and Femiest (R); second generation transdermal estrogen delivery systems marketed as Vivelle-Dot (R) and Estradot (R); transdermal combination estrogen/progestin delivery systems marketed under the brand names CombiPatch (R) and Estalis(R) and a transdermal methylphenidate system for ADHD marketed under the brand name Daytrana(TM). The Group operates in the United States and its products are marketed globally through licensees. Develops, manufactures and markets advanced transdermal drug delivery technologies & prescription transdermal products